Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HAO logo HAO
Upturn stock ratingUpturn stock rating
HAO logo

Haoxi Health Technology Limited Class A Ordinary Shares (HAO)

Upturn stock ratingUpturn stock rating
$1.17
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

08/28/2025: HAO (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -18.9%
Avg. Invested days 17
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 08/28/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 3.77M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta 1.28
52 Weeks Range 1.02 - 173.25
Updated Date 06/29/2025
52 Weeks Range 1.02 - 173.25
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -2.85

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 0.61%
Operating Margin (TTM) -0.53%

Management Effectiveness

Return on Assets (TTM) 3.42%
Return on Equity (TTM) 2.92%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -4130603
Price to Sales(TTM) 0.08
Enterprise Value -4130603
Price to Sales(TTM) 0.08
Enterprise Value to Revenue 0.63
Enterprise Value to EBITDA 17.37
Shares Outstanding 2205800
Shares Floating 1686284
Shares Outstanding 2205800
Shares Floating 1686284
Percent Insiders 21.79
Percent Institutions 5.78

ai summary icon Upturn AI SWOT

Haoxi Health Technology Limited Class A Ordinary Shares

stock logo

Company Overview

overview logo History and Background

Haoxi Health Technology Limited Class A Ordinary Shares operates within the telehealth and online healthcare services sector, primarily focusing on the Chinese market. Details regarding its founding year and specific milestones require further research due to limited publicly available information.

business area logo Core Business Areas

  • Online Pharmacy: Providing a platform for purchasing prescription and over-the-counter medications online.
  • Telemedicine Consultations: Connecting patients with doctors and specialists for remote medical consultations.
  • Health Information and Education: Offering health-related content and educational resources to users.

leadership logo Leadership and Structure

Information regarding the specific leadership team and organizational structure of Haoxi Health Technology Limited Class A Ordinary Shares is not readily available. Further research and company filings would be needed.

Top Products and Market Share

overview logo Key Offerings

  • Online Prescription Refills: Facilitating the refill of prescriptions through its online platform. Market share data is difficult to determine specifically for Haoxi Health due to limited public information. Competitors include Ali Health (0241.HK) and JD Health (6618.HK).
  • Virtual Doctor Consultations: Offering virtual consultations with healthcare professionals. Market share data is difficult to determine specifically for Haoxi Health due to limited public information. Competitors include Ali Health (0241.HK) and JD Health (6618.HK).

Market Dynamics

industry overview logo Industry Overview

The telehealth and online healthcare market is experiencing rapid growth, driven by increasing internet penetration, rising healthcare costs, and a growing demand for convenient healthcare solutions. The regulatory landscape is evolving, and competition is intensifying.

Positioning

Haoxi Health Technology Limited Class A Ordinary Shares aims to establish a strong presence in the Chinese online healthcare market. Competitive advantages may include partnerships with hospitals and pharmacies, and technological innovation.

Total Addressable Market (TAM)

The total addressable market for online healthcare in China is estimated to be significant, projected to reach hundreds of billions of US dollars in the coming years. Haoxi Health is positioned to capture a portion of this TAM by offering convenient and accessible online healthcare services. Details on exact TAM are dependent on scope and year of analysis.

Upturn SWOT Analysis

Strengths

  • Growing demand for online healthcare services
  • Potential partnerships with established healthcare providers
  • Technological capabilities in developing online platforms

Weaknesses

  • Limited brand recognition compared to larger competitors
  • Dependence on regulatory approvals
  • Potential data security and privacy concerns

Opportunities

  • Expansion into new healthcare services
  • Geographic expansion within China
  • Strategic acquisitions of complementary businesses

Threats

  • Intense competition from established players
  • Changes in government regulations
  • Economic slowdown in China

Competitors and Market Share

competitor logo Key Competitors

  • Ali Health (0241.HK)
  • JD Health (6618.HK)
  • Ping An Good Doctor (1833.HK)

Competitive Landscape

Haoxi Health faces intense competition from larger, more established players in the Chinese online healthcare market. To succeed, the company needs to differentiate itself through innovative services, strategic partnerships, and effective marketing.

Growth Trajectory and Initiatives

Historical Growth: Due to data limitations, a detailed historical growth analysis is not possible.

Future Projections: Analyst estimates for Haoxi Health Technology Limited Class A Ordinary Shares's future growth are unavailable. Future projection are dependant on the current economic and political standing.

Recent Initiatives: Information regarding recent strategic initiatives undertaken by Haoxi Health Technology Limited Class A Ordinary Shares is limited.

Summary

Haoxi Health Technology Limited aims to capitalize on the growing demand for online healthcare in China. However, the company faces significant competition from larger players and needs to strengthen its brand and secure regulatory approvals. Strategic partnerships and innovative services will be crucial for success. Further financial data is required for a comprehensive analysis.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Various financial news sources
  • Industry reports
  • Company website (if available)

Disclaimers:

The information provided is for general informational purposes only and should not be construed as financial advice. The data may be incomplete or inaccurate due to limited availability of public information. Consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Haoxi Health Technology Limited Class A Ordinary Shares

Exchange NASDAQ
Headquaters -
IPO Launch date 2008-01-30
Chairman & CEO Mr. Zhen Fan
Sector Communication Services
Industry Advertising Agencies
Full time employees 30
Full time employees 30

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. The company serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.